Commonwealth Equity Services’s AdvisorShares Alpha DNA Equity Sentiment ETF SENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,700
Closed -$527K 4067
2023
Q3
$527K Sell
23,700
-4,100
-15% -$96.4K ﹤0.01% 2550
2023
Q2
$670K Sell
27,800
-1,300
-4% -$29.7K ﹤0.01% 2390
2023
Q1
$674 Hold
29,100
﹤0.01% 2304
2022
Q4
$657K Sell
29,100
-3,400
-10% -$78.1K ﹤0.01% 2253
2022
Q3
$702K Hold
32,500
﹤0.01% 2150
2022
Q2
$673K Buy
32,500
+16,600
+104% +$371K ﹤0.01% 2201
2022
Q1
$380K Buy
+15,900
New +$392K ﹤0.01% 2764

Commonwealth Equity Services's SENT Position: Q4 2023 in Review

Commonwealth Equity Services sold out of AdvisorShares Alpha DNA Equity Sentiment ETF (SENT) in Q4 2023, closing a stake of 23,700 shares — an estimated $527K sold.

Commonwealth Equity Services first reported a position in SENT in Q1 2022 and held it in 7 quarters. The position peaked at $702K in Q3 2022. 0 funds tracked by Wall St. Rank hold SENT as of Q4 2023.

  • Commonwealth Equity Services reported no remaining AdvisorShares Alpha DNA Equity Sentiment ETF position as of Q4 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 23,700 AdvisorShares Alpha DNA Equity Sentiment ETF shares in Q4 2023, an estimated $527K.
  • Commonwealth Equity Services first reported a position in AdvisorShares Alpha DNA Equity Sentiment ETF in Q1 2022 and held it in 7 quarters.
  • Commonwealth Equity Services's AdvisorShares Alpha DNA Equity Sentiment ETF position peaked at $702K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held AdvisorShares Alpha DNA Equity Sentiment ETF as of Q4 2023.

Based on Commonwealth Equity Services's 13F filing for Q4 2023, filed 6 Feb 2024.